Open-Label Study of the Efficacy, Safety, and Durability of Peanut Sublingual Immunotherapy in Peanut-Allergic Children. Kelso JM. Pediatrics 2024;154.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kelso JM. Open-Label Study of the Efficacy, Safety, and Durability of Peanut Sublingual Immunotherapy in Peanut-Allergic Children. Pediatrics 2024;154.
PMID: 39620760